ir.orchard-tx.com Open in urlscan Pro
2.21.20.20  Public Scan

Submitted URL: http://ir.orchard-tx.com/
Effective URL: https://ir.orchard-tx.com/
Submission: On November 08 via api from US — Scanned from IT

Form analysis 0 forms found in the DOM

Text Content

Skip to main navigation
 * Investors & Media
 * Culture
 * News and Views
 * Contact

 * About
 * Approach
 * Focus
 * Families
 * Healthcare Professionals

 * Overview
 * News & Events
   * News & Press Releases
   * Events
   * Presentations
 * Financials & Filings
   * SEC Filings
   * Annual Reports
   * Quarterly Results
   * 2023 PFIC Annual Information Statement
 * Investor Resources
   * Investor Contact
   * Email Alerts


INVESTORS & MEDIA


INVESTORS & MEDIA

Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader
focused on ending the devastation caused by genetic and other severe diseases by
discovering, developing, and commercializing new treatments that tap into the
curative potential of hematopoietic stem cell (HSC) gene therapy. In this
approach, a patient’s own blood stem cells are genetically modified outside of
the body and then reinserted, with the goal of correcting the underlying cause
of disease with a single treatment.

Founded in 2015, Orchard’s roots go back to some of the first research and
clinical developments involving HSC gene therapy. Our team has played a central
role in the evolution of this technology from a promising scientific idea to a
potentially life-transforming reality. Today, Orchard is advancing a pipeline of
HSC gene therapies designed to address serious diseases where the burden is
immense for patients, families and society and current treatment options are
limited or do not exist.


FIND OUT MORE ABOUT ORCHARD

News & Press Releases
Oct 23, 2024
Orchard Therapeutics Announces Multiple Data Presentations and Publications
Oct 07, 2024
Orchard Therapeutics and Er-Kim Announce Partnership to Broaden Access to
Libmeldy to Eligible Patients in Turkey and Certain Eurasian Countries
Aug 28, 2024
Orchard Therapeutics Announces Multiple Presentations from across its Late-stage
Neurometabolic Portfolio at SSIEM 2024


View all
Events
More events are coming soon.


View all
Fact Sheet
More information is coming soon.


Corporate Presentation
More information is coming soon.



Print Page Email Page Email Alerts RSS Feeds
© Orchard Therapeutics plc.
 * About
   * Approach
   * Focus
   * Families
   * Healthcare Professionals
 * Investors & Media
   * Culture
   * News and Views
   * Contact
 * Privacy Policy
   * Cookie Policy
   * Terms & Conditions
   * Twitter
   * Linkedin

The site uses cookies to provide you with a more responsive and personalized
service. By using this site, you agree to our use of cookies as set out in our
cookie notice.

Please read our privacy notice and cookie notice for more information on the
cookies we use and how to delete or block the use of cookies.

I agree to using cookies